1,000-Star quarterly health-review template¶
Copy this template into a dated evidence document. Replace every placeholder; do not delete an unanswered field. The review is a decision record, not a marketing update.
Review identity¶
| Field | Value |
|---|---|
| Review window | YYYY-MM-DD through YYYY-MM-DD |
| Captured at | YYYY-MM-DDTHH:MM:SSZ |
| Current phase | G0–G9 |
| Source revision | full 40-character public or explicitly local-only Git SHA |
| Reviewer | role or approved public identity |
| Decision | ADVANCE, HOLD, REPLAN, or SUSTAIN |
| Next review | YYYY-MM-DD |
Outcome summary¶
In five sentences or fewer, state what became easier, what remains unsafe or unproven, and why the selected decision follows from the evidence.
Phase exits¶
| Required exit | Status | Evidence | Blocker / next action |
|---|---|---|---|
| replace with every exit for the current phase | PASS, FAIL, or INCOMPLETE |
repository-relative path or public URL | exact condition and owner |
No phase advances with a missing row or an INCOMPLETE quality exit. A Star
checkpoint is reported separately and cannot turn an exit into PASS.
Funnel scorecard¶
| Stage | Current value | Prior comparable value | Interpretation |
|---|---|---|---|
| Stars | — | — | lagging discovery signal |
| 14-day qualified referrals | — | — | top-referrer limitation stated |
| Primary bundle downloads | — | — | release and age stated |
| Independent first maps | — | — | accepted cumulative / attempted window |
| First-run completion and active time | — | — | sample size and workflow stated |
| External PRs / merged contributors | — | — | 90-day / 180-day windows |
| Untriaged issues and response time | — | — | support scope stated |
| Stable release age | — | — | exception, if any, stated |
| Review-owner coverage | — | — | named domain, not only a count |
Use privacy-bounded aggregates. Do not include stargazer, issue-author, validator, or contributor identities without a separate reason and consent.
Product and evidence health¶
| Check | Status | Evidence / finding |
|---|---|---|
| Supported P0/P1 queue | — | — |
| Clean install and upgrade | — | — |
| Canonical first-map path | — | — |
| Release rollback/recovery | — | — |
| Public claim reproduction | — | — |
| Dependency and license drift | — | — |
| Private/local-only critical input | — | — |
Capacity and ownership¶
| Signal | State |
|---|---|
| Product/community/research allocation | — |
| Product WIP | — |
| Community WIP | — |
| Research WIP | — |
| Contributions awaiting substantive review | — |
| Single-owner procedure or subsystem | — |
| Support load exception | — |
State which scope will be reduced if capacity is insufficient. Do not reduce a quality gate to fit the quarter.
Experiment decisions¶
| Previous experiment | Baseline | Result | Decision and reason |
|---|---|---|---|
| one row per active experiment | — | — | CONTINUE, STOP, or REDIRECT |
Largest current constraint¶
Name exactly one constraint in the discovery → activation → trust → contribution → sustainability chain. Include the evidence that makes it larger than the alternatives.
Next bounded portfolio¶
| Slice | Outcome | Owner | Stop condition | Due/review date |
|---|---|---|---|---|
| Product/release | one outcome | — | — | — |
| Community | one outcome | — | — | — |
| Research | zero or one outcome | — | — | — |
External-action state¶
| Gate | State | Exact authorized scope or blocker |
|---|---|---|
| E1 source publication | AUTHORIZED or NOT_AUTHORIZED |
— |
| E2 artifact publication | AUTHORIZED or NOT_AUTHORIZED |
— |
| E3 community mutation | AUTHORIZED or NOT_AUTHORIZED |
— |
| E4 stable release | AUTHORIZED or NOT_AUTHORIZED |
— |
Authorization for one row must not be copied into another.
Final decision¶
Record ADVANCE, HOLD, REPLAN, or SUSTAIN, the evidence-based reason,
the next review date, and the person or role responsible for the next bounded
outcome.